This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Illinois. Active years: 2019-2021.
Company Filing History:
2 out of 3,690 
2 out of 2,421 
Years Active: 2019-2021
Title: The Innovations of Ben Hitchinson
Introduction
Ben Hitchinson is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of biomedical research, particularly in the area of peptide analogs and their applications in treating diseases. With a total of 2 patents, his work has garnered attention for its potential impact on health and medicine.
Latest Patents
Hitchinson's latest patents focus on the peptide inhibition of CCR3-mediated diseases or conditions. His innovative approach involves a C-C chemokine receptor 3 (CCR3) peptide analog that exhibits biased antagonism. This peptide binds to and inhibits ligand-mediated signaling and chemotaxis while promoting the internalization and degradation of CCR3. The method he developed aims to treat, prevent, or ameliorate symptoms associated with eosinophil- or CCR3-mediated diseases or conditions.
Career Highlights
Throughout his career, Ben Hitchinson has worked with notable institutions, including the University of Illinois and the United States Department of Health and Human Services. His research has contributed to advancements in understanding and treating various medical conditions.
Collaborations
Hitchinson has collaborated with esteemed colleagues such as Steven Jules Ackerman and Fan Gao Laffey. These partnerships have further enriched his research and innovation efforts.
Conclusion
Ben Hitchinson's work exemplifies the spirit of innovation in the biomedical field. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.